News|Articles|June 26, 2026

Previewing women's health regulatory updates and conferences in the 2nd half of 2026

Fact checked by: Joshua Fitch, Senior Editor

A look ahead to the second half of 2026 for ob-gyns, including Viatris's pending FDA decision on a low-dose estrogen contraceptive patch and previews of the IDSOG, AUGS PFD Week, and The Menopause Society annual meetings.

We're officially at the halfway point of the year, and the back half is shaping up to be just as active as the first for women's health. Below, the Contemporary OB/GYN team looks ahead to a pending FDA decision in the contraception space, along with the leading medical society meetings on the calendar for the remainder of 2026.